|
| 16alpha,17,21-trihydroxypregna-1,4,9(11)-triene-3,20-dione 21-acetate Basic information |
Product Name: | 16alpha,17,21-trihydroxypregna-1,4,9(11)-triene-3,20-dione 21-acetate | Synonyms: | 16alpha,17,21-trihydroxypregna-1,4,9(11)-triene-3,20-dione 21-acetate;16,17-Dihydroxypregna-1,4,9(11)-triene-3,20-dione 21-acetate;16-alpha,17-alpha-dihydroxy-3,20-dioxopregna- 1,4,9(11)-trien-21-yl acetate;Pregna-1,4,9(11)-triene-16,17-diol-3,20-dione 21-acetate;21-(Acetyloxy)-16α,17-dihydroxypregna-1,4,9(11)-triene-3,20-dione;(16α)-21-Acetyloxy-16,17-dihydroxy-pregna-1,4,9(11)-triene-3,20-dione;BNKY015-BD01;Budesonide Impurity 12 | CAS: | 77017-20-0 | MF: | C23H28O6 | MW: | 400.46482 | EINECS: | 278-593-2 | Product Categories: | Intermediates & Fine Chemicals;Pharmaceuticals;Steroids | Mol File: | 77017-20-0.mol | |
| 16alpha,17,21-trihydroxypregna-1,4,9(11)-triene-3,20-dione 21-acetate Chemical Properties |
Melting point | 213-215 °C(Solv: acetone (67-64-1); ligroine (8032-32-4)) | Boiling point | 576.7±50.0 °C(Predicted) | density | 1.31±0.1 g/cm3(Predicted) | solubility | soluble in Acetone, Dichloromethane | pka | 11.92±0.70(Predicted) | Water Solubility | 38.72mg/L at 25℃ | LogP | 2.26 at 25℃ |
| 16alpha,17,21-trihydroxypregna-1,4,9(11)-triene-3,20-dione 21-acetate Usage And Synthesis |
Uses | Intermediate in the preparation of antiinflammatory compounds. |
| 16alpha,17,21-trihydroxypregna-1,4,9(11)-triene-3,20-dione 21-acetate Preparation Products And Raw materials |
|